Kearns Evan 4
4 · Cogent Biosciences, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4
Kearns Evan
Chief Legal Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-02-13+140,000→ 140,000 totalExercise: $13.63Exp: 2033-02-13→ Common Stock (140,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.